Financial Results & Results Press Release for March 31, 2015 (Standalone) (Audited)
Novartis India Ltd has informed BSE about the Standalone Financial Results & a copy of Results Press Release for the period ended March 31, 2015.27-05-2015
27-05-2015
Update on announcement made by the Company on November 07, 2014 in the transfer of Animal Health Division
Novartis India Ltd has informed BSE about Update on announcement made by the Company on November 07, 2014 in the transfer of Animal Health Division.27-05-2015
Code of Conduct of Fair Disclosure
Novartis India Ltd has informed BSE that, pursuant to Regulation 8 and Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Board of Directors has adopted the following codes to be effective from May 15, 2015:1. Code of practices and procedures for fair disclosure of unpublished price sensitive information and2. Code of conduct to regulate, monitor and report share trading by Insiders.15-05-2015
Board to consider Dividend
Novartis India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 27, 2015, inter-alia, to consider:1. Approval of audited annual accounts for the year ended March 31, 2015;2. Recommend dividend for the period mentioned above.15-05-2015
Shareholding Pattern For March 31, 2015
Novartis India Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.14-04-2015
Results Press Release
Novartis India Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2014.04-02-2015
Financial Results & Limited Review for Dec 31, 2014 (Standalone)
Novartis India Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.04-02-2015
Shareholding Pattern For December 31, 2014
Novartis India Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.15-01-2015
Novartis India approves transfer of its OTC Division to the consumer healthcare joint venture between Novartis AG and GSK
Novartis India Ltd has informed BSE regarding a Media Release titled "Novartis India approves transfer of its OTC Division to the consumer healthcare joint venture between Novartis AG and GSK".13-01-2015